Xinjie Meng
Hong Kong Science And Technology Park
Hong Kong, China
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants.
Journal: Emerging microbes & infections
Published: August 03, 2026
Generation of Nasal Cell-Derived Human Alveolar Organoids and Organoid-Macrophage Assembloids for in Vitro Lung Modeling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 19, 2026
A branched peptide targets virus and host to block influenza virus and rhinovirus entry.
Journal: Antimicrobial agents and chemotherapy
Published: June 25, 2025
Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2.
Journal: International journal of molecular sciences
Published: June 03, 2022
Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo.
Journal: Signal transduction and targeted therapy
Published: May 15, 2022
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
Journal: Emerging microbes & infections
Published: March 08, 2022
A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters.
Journal: Cell discovery
Published: January 06, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026